What's new

3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2025, 09:30 (CEST) to 2 April 2025, 10:30 (CEST)

3Rs Working Party (3RsWP) plenary meeting - Public sess...

Mar 5, 2025 0

3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work...

Human medicines European public assessment report (EPAR): Skyrizi, risankizumab, Date of authorisation: 26/04/2019, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Skyrizi, risankizumab,...

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, lenalidomide, Date of authorisation: 18/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Lenalidomide Mylan, le...

Minutes - PDCO minutes of the 12-15 November 2024 meeting

Mar 5, 2025 0

Minutes - PDCO minutes of the 12-15 November 2024 meeting

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Remsima, infliximab, D...

Frequently asked questions (FAQs) : How to create and s...

Mar 5, 2025 0

Frequently asked questions (FAQs) : How to create and submit an annual safety re...

Frequently asked questions (FAQs): How to create, submi...

Mar 5, 2025 0

Frequently asked questions (FAQs): How to create, submit and withdraw a Clinical...

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Da...

CHMP opinions on consultation procedures

CHMP opinions on consultation procedures

Mar 5, 2025 0

CHMP opinions on consultation procedures

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Da...

Human medicines European public assessment report (EPAR): Awiqli, Insulin icodec, Date of authorisation: 17/05/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Awiqli, Insulin icodec...

Union Product Database: release notes

Union Product Database: release notes

Mar 5, 2025 0

Union Product Database: release notes

Human medicines European public assessment report (EPAR): Alimta, pemetrexed, Date of authorisation: 20/09/2004, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Alimta, pemetrexed, Da...

Vitrolife IVF media - Procedural steps and scientific i...

Mar 5, 2025 0

Vitrolife IVF media - Procedural steps and scientific information after initial ...

Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation: 08/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): Inrebic, fedratinib, D...

Human medicines European public assessment report (EPAR): ReFacto AF, moroctocog alfa, Date of authorisation: 13/04/1999, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025 0

Human medicines European public assessment report (EPAR): ReFacto AF, moroctocog...

Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Ibandronic acid Accord...

Human medicines European public assessment report (EPAR): Coagadex, human coagulation factor X, Date of authorisation: 16/03/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Coagadex, human coagul...

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Date of authorisation: 13/09/1998, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Da...

Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, Date of authorisation: 20/04/2007, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, ...

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreoti...

EMEA-002727-PIP02-23

EMEA-002727-PIP02-23

Mar 4, 2025 0

EMEA-002727-PIP02-23

Human medicines European public assessment report (EPAR): Viramune, nevirapine, Date of authorisation: 04/02/1998, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Viramune, nevirapine, ...

Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec,insulin aspart, Date of authorisation: 21/01/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Ryzodeg, insulin deglu...

33
34
35
36
37

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.